We studied whether delayed posttreatment with the nitric oxide donor 3-morpholinosydnonimine (SIN -1) is effective in reducing the size of the infarct pro duced by occlusion of the middle cerebral artery (MCA) in spontaneously hypertensive rats (SHRs). SHRs were anesthetized with halothane and intubated transorally. The left MCA was occluded at the level of the inferior cerebral vein. Cerebral blood flow (CBF) was monitored in the ischemic hemisphere by a laser-Doppler flowme ter, and an electroencephalogram (EEG) was recorded. SIN-I was infused into the left internal carotid artery for 60 min starting 3, 15, 30, 60 or 120 min after MCA occlu sion. The hypotension associated with SIN-I administra tion was controlled by i. v. administration of phenyleph rine. At the end of the infusion, rats were extubated and allowed to recover. Infarct size was measured 24 h later on thionin-stained coronal brain sections by computer-We recently demonstrated that intracarotid ad ministration of the nitric oxide (NO)-generating agents sodium nitroprusside and 3-morpholinosyd nonimine (SIN -1) increases cerebral blood flow (CBF) in the ischemic territory and reduces the size of the infarct resulting from occlusion of the middle cerebral artery (MCA) in the rat (Zhang and Iade cola, 1993a; Zhang et a\., 1994) . The "protective" effect is dose-related and is specific for NO donors because the NO-independent vasodilator papaver ine does not reduce the size of the infarct (Zhang et
assisted planimetry. SIN-I infusion 3 min after MCA oc clusion enhanced the recovery of CBF and EEG ampli tude and reduced the size of the infarct by 30 ± II % (p < 0.05, analysis of variance). The reduction in infarct size by SIN -I was still seen when SIN -I was administered 15, 30, and 60 min after MCA occlusion (p < 0.05). However, administration of SIN-I 2 h after MCA occlusion did not affect the size of the infarct (p > 0.05). We conclude that posttreatment with SIN-I is effective in reducing focal ischemic damage if this agent is administered up to 60 min after MCA'occiusion. Thus, NO donors, alone or in com bination with other treatment modalities, may have ther apeutic potential in the management of acute ischemic stroke. Key Words: Middle cerebral artery-Cerebral blood flow-laser-Doppler flowmetry-SIN-I Spontaneously hypertensive rats.
aI., 1994). Infusion of NO donors does not affect platelet aggregation assessed ex vivo (Zhang et al., 1994) . These observations indicate that NO donors protect the ischemic tissue at risk for stroke by en hancing collateral flow to the ischemic territory and raise the possibility that these agents could be used in the treatment of acute cerebral ischemia.
In earlier experiments, however, NO donors were administered 3-5 min after MCA occlusion. Therefore, it remains to established whether these agents are effective if they are administered later after induction of ischemia. This issue is obviously important for the evaluation of the therapeutic po tential of NO donors because most stroke patients reach medical attention after the occurrence of ce rebral ischemia. In the present study, we investi gated the time course of the protective effect of posttreatment with the NO donor SIN-l (Feelisch, 1991) . We found that SIN-l reduces focal ischemic damage when administered up to 60 min after MCA occlusion. Thus, NO donors, unlike many neuro-protective agents, are effective even when admin istered well after occurrence of cerebral ischemia, therefore, they are potentially useful in the treat ment of acute ischemic stroke in human.
METHODS
Methods for MCA occlusion, for monitoring of CBF by laser-Doppler flow me try (LDF), and for determination of infarct size have been previously described in detail (Zhang and ladecola, 1992; 1993a , 1993b Zhang et aI., 1994) and are only summarized here.
General surgical procedures
Studies were conducted on 39 male spontaneously hy pertensive rats (SHRs) (Harland) weighing 30�00 g. An imals were not fasted. Anesthesia was induced with halo thane (5% in 100% oxygen) administered through a facial mask. When deeply anesthetized, all rats were intubated transorally as previously described (Zhang and ladecola, 1993b) . Briefly, the epiglottis and vocal cords were visu alized with the aid of a fiberoptic illuminator and a poly ethylene catheter (outer diameter, 2.8 mm) was gently advanced through the oral cavity into the trachea. The left external carotid artery was cannulated centripetally, and the catheter was advanced toward the carotid bifur cation and secured in place (Zhang and ladecola, 1993a) . The femoral vessels were also cannulated. Rats were placed on a stereotaxic frame (Kopf) and artificially ven tilated with 100% oxygen by a mechanical ventilator (Ro dent Respirator, Harvard Apparatus). At this time, the halothane concentration was reduced to I %. Ventilation with 100% O2 was used because in preliminary studies it was found that hyperoxia facilitates the recovery of the animals after extubation. Although hyperoxia could re duce the half-life of NO (Archer, 1993) , the observation that the vasodilator effect of NO donors is preserved sug gests that, in this model, NO still exerts its biological actions despite an elevated Po2• Body temperature was maintained at 37 ± OSC by a thermostatically controlled infrared lamp connected to a rectal probe. Although brain temperature was not monitored in these experiments, it is unlikely that the protective effect of NO donors is due to brain hypothermia because infusion of these agents does not influence brain temperature (Zhang et aI., 1994) . One of the femoral arterial catheters was used for continuous recording of arterial pressure (AP), mean AP, and heart rate. The other catheter was used for blood sampling for measurement of Pao2, Paco2, and pH by a blood-gas an alyzer (Corning, model 178).
Monitoring of CBF and electroencephalogram
CBF was monitored in the cerebral cortex ipsilateral to the occluded MCA using LDF (Vasamedic, BPM 403A) Iadecola, 1993a, 1993b; Zhang et aI., 1994) . A small hole, 1-2 mm in diameter, was drilled with the as sistance of a dissecting scope at a site 2.5-3 mm lateral to the midline and 4.2 ± 0.7 mm rostral to the interaural line. This site corresponds to the region of the cerebral cortex that is rescued from infarction by NO donors (Zhang and ladecola, 1993a; Zhang et aI., 1994) . The dura was left intact, and the LDF probe (tip diameter, 0.8 mm) was positioned 0.5 mm above the dural surface. The analog output of the flowmeter was fed into a direct-current am plifier (Grass) and displayed on the polygraph. The elec-troencephalogram (EEG) was recorded monopolarly from a stainless steel screw inserted through to the skull at a site 2 mm lateral to midline and 1 mm rostral to the LDF probe. The reference electrode was a clip attached to the scalp. For quantitation of the EEG changes in duced by ischemia, the mean amplitude of the dominant frequency was measured on 30-s EEG epochs (Zhang and ladecola, 1992) . These EEG segments corresponded to the time points at which CBF was measured. The reduc tion in EEG amplitude after MCA occlusion is a good indicator of the severity of ischemia, and the degree of recovery in EEG amplitude after ischemia correlates well with histological outcome (Salgado et aI., 1989; Uematsu et aI., 1991; Zhang and Iadecola, 1992; Iade cola, 1993a, 1993b) .
Occlusion of the MCA and determination of infarct volumes
Procedures for MCA occlusion and for determination of the infarct volume are identical to those published pre viously (Zhang and Iadecola, 1992 , 1993a , 1993b Zhang et aI., 1994) . Briefly, for MCA occlusion a 3-4 mm hole was drilled at a site superior and lateral to the left foramen ovale to expose the distal portion of the left MCA. The MCA was elevated and cauterized medial to the inferior border of the inferior cerebral vein (Zhang et aI., 1994) . Twenty-four hours after MCA occlusion, rats were killed and their brains were removed. The site of CBF recording was marked, and the brain was frozen in cooled isopen tane ( -30°C). Coronal sections (thickness, 30 fJ,m) were serially cut in a cryostat, collected at 300-fJ,m intervals, and stained with thionin. Infarct volume was determined using an image analyzer (MCID, Imaging Research Inc.) as previously described (Zhang and Iadecola, 1992 , 1993a , 1993b Zhang et aI., 1994) .
Experimental protocol
After surgical exposure of the MCA, arterial blood gases were adjusted so that arterial Pco2 was between 33 and 38 mm Hg (Table 1) . The MCA was then occluded as already described. Occurrence of neocortical ischemia was indicated by a drop in CBF followed by a reduction in the amplitUde of the EEG. Approximately 3,15,30,60, and 120 min after MCA occlusion, normal saline (vehicle) or SIN-I (3 mg/kg/h; Cassella AG) was infused into the external carotid catheter for I h at a rate of 1 ml/h. SIN-l was dissolved in saline. The concentration of SIN-l used in these experiments was found in a previous study to reduce infarct size maximally (Zhang et aI., 1994) . To counteract the hypotension associated with SIN -1 admin istration, an i. v. infusion (0.5-1 ml/h) of phenylephrine (10-100 fJ,g/h) was also begun (Zhang and ladecola, 1993a; Zhang et aI., 1994) . In rats receiving intracarotid infusions of vehicle, saline was administered i. v. We have previ ously demonstrated that infusion of NO donors or saline does not produce significant hemodilution (Zhang and Ia decola, 1993a; Zhang et aI., 1994) . SIN-l infusion ele vates plasma glucose slightly (=20%), an effect probably secondary to coinfusion of phenylephrine (Zhang et aI., 1994) . At the end of the infusion period, animals were monitored to assure that the AP was stable. Cannulas were then removed from trachea and blood vessels. Wounds were infiltrated with lidocaine and sutured. Body temperature was monitored and maintained at 37°C until rats regained consciousness. Animals were carefully ob served during the postoperative period. Seizures were not Values are means ± SD; there were no significant differences between groups (p > 0.05, ANOVA and Tukey's test). Arterial pressure values refer to the time before and 5, 10, 30, and 60 min after the start of the infusion of vehicle or drugs.
observed in any of the animals studied. Twenty-four hours later, rats were killed for determination of infarct size. Only a few rats died before the end of the experi ments (none or one rat per group); these rats died after extubation because of respiratory insufficiency due to tra cheal and laryngeal edema.
Data analysis
Data are expressed as means ± SD. Comparisons among multiple groups were statistically evaluated by the analysis of variance (ANOV A) and the Tukey-Kramer modification of Tukey's test (Systat, Inc.). Differences were considered significant at p < 0.05.
RESULTS
Effect of SIN -1 posttreatment on the size of the infarct resulting from MCA occlusion
The AP and blood gases of the rats studied are presented in Table 1 . These variables did not differ between groups (p > 0.05, ANOVA and Tukey's test). In rats in which vehicle was administered, MCA occlusion produced an infarct restricted mostly to the neocortex ( Table 2 ). The magnitude and regional distribution of the lesion were similar to those previously reported in SHRs by this and other laboratories (Morikawa et aI., 1992; Ya mamoto et aI., 1992; Zhang et aI., 1994) . As before (Zhang et aI., 1994 ) SIN-l administration 3 min after MCA occlusion reduced the size of the total infarct by 30 ± 11% (p < 0.05, ANOVA and Tukey's test).
The regional distribution of the tissue rescued from infarction was identical to that previously reported (Zhang et aI., 1994) and involved the border zones between the arterial territories of the MCA and those of the anterior and posterior cerebral arteries. SIN-l administration 15, 30, and 60 min after MCA occlusion also reduced the infarct size in neocortex (Table 2 and Fig. 1 ; P < 0.05). However, SIN-l administration 2 h after MCA occlusion did not re duce the size of the infarct (p > 0.05).
Effect of SIN-l posttreatment on the recovery of CBF and EEG amplitude MCA occlusion resulted in a reduction in CBF and EEG amplitude ( Table 3 ). The initial reduction in CBF and EEG amplitude did not differ between the groups of animals studied (p > 0.05, ANOV A and Tukey's test). In vehicle-treated rats, CBF and EEG amplitude recovered by 10 ± 9 and 20 ± 13%, respectively, 60 min after MCA occlusion (Table 3) . SIN-l increased the recovery of CBF when it was administered 5 or 15 min after MCA occlusion (p < 0.05). Although CBF recovery at 30 and 60 min was increased, the change did not reach statistical sig nificance (p > 0.05). The recovery of the EEG am plitude was increased when SIN -1 was adminis tered up to 60 min after MCA occlusion (p < 0.05). SIN-l administration 2 h after MCA occlusion did not affect the recovery of CBF and EGG amplitude (p> 0.05).
DISCUSSION
We have demonstrated that administration of the NO donor SIN-l reduces the size of the infarct and enhances the recovery of CBF after occlusion of the MCA and that the effect is still present when treat ment is delayed up to 60 min after induction of isch emia. These observations indicate that posttreat ment with NO donors is effective in protecting brain tissues from ischemic damage.
The reduction in infarct size observed with SIN-l admini'&tration cannot be a consequence of differ ences in 1\.. 1> ()l" o\om\ gases oecause tn.ese parame ters were carefully controlled and did not differ among groups. Nor can the protective effect be a consequence of differences in plasma glucose b e tween treated and untreated groups; we have pre viously demonstrated that in the animals treated with NO donors, plasma glucose was increased """ 20% and hyperglycemia has been reported to in crease, not decrease, focal ischemic damage (Prado et aI., 1988) . Furthermore, the reduction in infarct size is unlikely to be due to the elevated arterial P02 of the rats because hyperoxia was present both in treated and untreated rats. The possibility that the b e neficial effect of NO donors occurs only with high P02 tensions is also unlikely, because hyper-oxia should facilitate the reaction of NO with su peroxide anions, resulting in peroxynitrite forma tion and generation of hydroxyl radicals and nitro gen dioxide (Beckman et aI., 1990) . Hydroxyl radicals and nitrogen dioxide are highly toxic and should worsen, not ameliorate, tissue damage. In addition, hyperoxia may also enhance the produc tion of potentially toxic free radicals by SIN-l (Hogg et aI., 1992) . Therefore, the high P02 of the animals is unlikely to contribute to the reduction in tissue damage exerted by NO donors.
Many of the pharmacological agents demon strated to reduce ischemic damage in rat models of permanent focal ischemia are not efficacious when administered after induction of ischemia. For exam ple, the calcium channel antagonist nimodipine, an agent reported to reduce the extent of ischemic damage by 38% when administered before MCA oc clusion (Mohamed et aI., 1985) , was not effective when administered 5 min after MCA occlusion in Sprague-Dawley rats (Gotoh et aI., 1986) . Although administration of MK801, an NMDA receptor an tagonist, 30 min after permanent MCA occlusion was found to be protective (Park et aI., 1988) , the broad-spectrum glutamate-receptor antagonist kynurenic acid was not effective when given 60 min after MCA occlusion (Germano et aI., 1987) . Similarly, the lipid-peroxidase-inhibitor 21amino steroids reduce focal ischemic damage if ad ministered before and after ischemia and only at the highest doses tested (Bech and Bielenberg, 1991) . Therefore, the finding that delayed treatment with NO donors is highly effective in reducing focal isch emic damage indicates that the protective action of these agents is substantial and underscores their therapeutic potential.
Although there is stilI controversy regarding the role of NO in the pathogenesis of cerebral ischemic damage [see Iadecola et al. (1994) for a review], several inde\lendent l\.ne� of evidence indicate that tn.e va'&oui\ator action ai "NO is beneikia\ in the early phases of focal cerebral ischemia. First, NO donors enhance CBF to the ischemic tissue and re duce the ischemic damage produced by MeA oc clusion (Zhang and Iadecola, 1993a; Zhang et aI., 1994; present study) , an effect that does not seem to depend on the antiplatelet action of NO (Zhang et aI., 1994) . Second, administration of the NO pre cursor L-arginine enhances intraischemic CBF and reduces brain damage after MCA occlusion (Morikawa et aI., 1992) . Third, stimulation of the cerebellar fastigial nucleus (FN), a procedure that increases cortical CBF by stimulating local produc tion of NO [see Iadecola 1993 , for a review], re duces the ischemic damage following MCA occlu- sion by increasing local CBF (Zhang and Iadecola, 1993b) . However, evidence that the mechanism of the protection exerted by FN stimulation may not rely on increased CBF has also been presented (Ya mamoto et al., 1993) . Fourth, ablation of the NO producing parasympathetic nerves originating in the sphenopalatine ganglia (Iadecola et al., 1993) en larges the infarct resulting from MCA occlusion (Kano et al., 199 1) . Fifth, administration of NO syn thase inhibitors increases the size of the infarct after MCA occlusion (Yamamoto et al., 1992; Zhang and Iadecola, 1993a) ; however, this finding remains controversial (Nowicki et al., 1991; Buisson et al., 1992; Nagafuji et al., 1992) . These observations, collectively, suggest that in the early phases of ce rebral ischemia, NO may reduce ischemic damage by producing vascular relaxation and increasing collateral blood flow to the ischemic territory. The flow increase may' 'rescue" marginally perfused re gions at risk for infarction. This hypothesis is sup ported by the observation that the anatomical dis tribution of the region spared from infarction corre sponds to the location of the so-called ischemic penumbra, i.e., the oligemic area surrounding the ischemic core in which the tissue is still viable; this region can be retrieved from infarction if normal perfusion is reestablished [Astrup et al., 1981 ; see Choi (1990) for additional references].
On the other hand, the present results do not completely rule out the possibility that the protec tive effect of NO donors may be due to a "cytopro tective" action of these drugs and not to their vas cular effect. Indeed, NO donors reduce the rise in intracellular calcium elicited by NMDA receptor activation and attenuate NMDA-induced neuronal death in vitro (Manzoni et al., 1992; Lipton et al., 1993) . These observations suggest that these agents could also reduce ischemic damage by limiting ex citotoxicity in the ischemic penumbra (Choi, 1990) . Other studies, however, have found that NO donors J Cereb Blood Flow Metab, Vol. 14, No.4, 1994 are neurotoxic (e,g" Dawson et aL, 199 1). The con troversy may be due, at least in part, to the fact that NO donors can be neurotoxic or neuroprotective depending on the redox state of the medium. Neu rotoxicity may occur under conditions favoring for mation of NO radical (NO"), leading to free radical damage, presumably through formation of peroxy nitrite anions (Beckman et aL, 1990; Lipton et aL, 1993) . Neuroprotection seems to occur under con ditions favoring formation of nitrosonium ion, which results in S-nitrosylation of NMDA receptor thiols and down-regulation of the receptor itself (Lipton et aL, 1993) . The recent finding that NO attenuates superoxide-or hydrogen peroxide induced free radical damage in primary neuronal cultures (Wink et aL, 1993) suggests another poten tial mechanism whereby NO could be neuroprotec tive in cerebral ischemia. Therefore, it remains to be established whether down-regulation of NMDA receptors and/or attenuation of free radical damage contributes to the protective effect of SIN-I .
The beneficial effect of NO donors in the early stages of cerebral ischemia also indicates that the increase in cerebral NO production that has been described at the onset of focal or global ischemia is not damaging to the tissue (Malinski et aL, 1993; Sato et aL, 1993; Tominaga et aL, 1993) . On the contrary, the NO surge may reflect a compensatory mechanism attempting to limit the severity of the ischemia. In support of this hypothesis are the re ports that inhibitors of NO synthesis worsen the outcome of focal cerebral ischemia (Yamamoto et aL, 1992; Zhang and Iadecola, 1993a) . However, as pointed out previously, there is no agreement on the effects of NO synthase inhibition on focal cerebral ischemic damage, and some laboratories have re ported that NO synthase inhibitors are protective in focal ischemia (e.g., Nowicki et aL, 1991; Buisson et aL, 1992 : Nagafuji et aL, 1992 . This controversy clearly indicates that the role of NO in cerebral ischemia is complex and remains to be fully eluci dated.
After 2 h of ischemia, NO donors fail to protect the brain tissue from infarction. The reasons why NO donors loose their effectiveness cannot be de termined on the basis of the present results. One possibility is that, after 120 min of ischemia, the tissue damage is already fully developed so that re gions at risk have already undergone infarction. In support of this hypothesis are the findings of Kap lan et al. (1991) that in SHRs the brain damage reaches a plateau after 2-3 h of focal ischemia. Also of interest is the finding that NO donors fail to in crease intraischemic CBF when they are infused 2 h after MCA occlusion. Perhaps sustained ischemia results in loss of reactivity of vascular smooth mus cles to NO. It remains to be determined whether such loss of vascular reactivity to NO could be, in part, responsible for the lack of protection by NO donors 2 h after MCA occlusion.
The finding that delayed treatment with NO do nors is effective in reducing focal ischemic damage indicates that these agents could potentially be use ful in the treatment of ischemic stroke. However, due to the associated hypotension, NO donors should be administered in an intensive care unit setting with careful monitoring of arterial pressure and other cardiovascular variables. Perhaps NO do nors could be administered in combination with other "anti-ischemic" agents (glutamate receptor antagonists, calcium channel antagonists, free radical scavengers, etc.) or with reperfusion ther apy, as has been proposed for glutamate recep tor antagonists [see Ginsberg et ai, (1990) for a review].
In conclusion, we have demonstrated that de layed administration of the NO donor SIN-I in creases intraischemic CBF and reduces the size of the infarct resulting from MCA occlusion. The pro tective effect exerted by this agent is present even when its administration is delayed up to 60 min after induction of ischemia. The finding that delayed treatment with SIN -I is effective in reducing focal ischemic damage indicates that NO donors, alone or in combination with other treatment modalities, have therapeutic potential in the acute management of ischemic stroke.
